venlafaxine hydrochloride
- Product NDC
- 68382-036
- 11-digit product format
- 683820036
- Labeler code
- 68382
- Product ID
- 68382-036_8c02c121-fe14-45f5-b2bc-b09fd377531f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- venlafaxine hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA090174
- Marketing category
- ANDA
- Marketing start
- 2011-06-01
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- venlafaxine hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| VENLAFAXINE HYDROCHLORIDE | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7D7RX5A8MO |
| Rxcui | 313581, 313583, 313585 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68382-036-06 | venlafaxine hydrochloride | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | | 16 |
| 68382-036-10 | venlafaxine hydrochloride | 1000 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 1000 | | 16 |
| 68382-036-16 | venlafaxine hydrochloride | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | | 16 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | INACTIVE INGREDIENT | P2OM2Q86BI | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | INACTIVE INGREDIENT | P2OM2Q86BI | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68382-036 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS USA INC.] | 16 | Current NDC, Legacy NDC, 3 package rows | 20221023_5351fe67-17d9-42ec-9e8b-6585fdb9e29e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68382-036-06 | 68382003606 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-06) | 2011-06-01 | 0000-00-00 | No | No | Current |
| 68382-036-10 | 68382003610 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-10) | 2011-06-01 | 0000-00-00 | No | No | Current |
| 68382-036-16 | 68382003616 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-16) | 2011-06-01 | 0000-00-00 | No | No | Current |